Quoin Pharmaceuticals (QNRX)

• Market cap: $12.1M
• 1 day: 3.29%
• 5 days: 0.77%
• 1 month: -25.36%
• 3 months: 105.26%
• 6 months: 56.55%
• Year to date: -38.51%
• 1 year: -40.8%
• 5 years: -99.97%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Employees: 3